Mesoblast Ltd

Research Mesoblast Ltd (MESO) on Bullrun: market cap USD 1.74B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMESO
• ExchangeNASDAQ
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.74B
• Financial periodQ1 2026
• Free cash flow-USD 4.46M

Valuation Snapshot

latest market cap is USD 1.74B.

About Mesoblast Ltd

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.

Frequently asked questions

What is Mesoblast Ltd's market cap?

Mesoblast Ltd's market capitalization is USD 1.74B.

What does Mesoblast Ltd do?

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.